Abstract
MOLECULAR CHARACTERIZATION OF METALLO BETA LACTAMASE PRODUCING CLINICAL ISOLATES OF PSEUDOMONAS AERUGINOSA

Shyamasree Nandy *, Ashish K. Asthana, Molly Madan

ABSTRACT

Present study was carried out in the Microbiology Dept of Subharthi Medical College, Meerut, UP. 56 non duplicate isolates of Pseudomonas aeruginosa resistant to either or both Imipenem and Meropenem were collected. Material and Methods: Four phenotypic methods were employed for screening of MBL namely Double disc synergy test (DDST) with Imipenem and 750μgEDTA, Combined Disc test with Imipenem EDTA & Meropenem EDTA, E Test with Imipenem EDTA.PCR was done for molecular characterization of the MBL producers. Results: Among 56 isolates 13 isolates were found to be MBL producer.09 of the isolates were carrying blaVIM and 04 were carrying blaIMP gene. No other gene were found. Maximum number of isolates were obtained in the age group 21 to 30 years. No MBL producer was found in Meropenem sensitive isolates.For screening of metallobetalactamase Meropenem was found to be a better marker than Imipenem.DDST with Imipenem and Meropenem was found to have same specificity and sensitivity. Etest failed to detect MBL in Imipenem sensitive isolates. All the MBL positive isolates showed resistance towards aminoglycosides. Colistin was 100% sensitive sitive and the next effective drug was Amikacin. In most of the MBL positive isolates Aztreonam was resistant.This can be attributed to the co presence of multiple mechanism of resistance in MBL positive isolates.

Keywords: MBL, Pseudomonas aeruginosa, bla VIM, bla IMP.


[Full Text Article]   [Download Certificate]

Indexing

Best Article Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: APRIL ISSUE PUBLISHED

    APRIL 2026 Issue has been successfully launched on 1 APRIL 2026.

  • EJBPS: New Impact Factor 2026

    EJBPS Impact Factor has been Increased from  7.482 to 8.181 for Year 2026.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

Google Scholar Index Copernicus Indian Science Publications Urlich's Periodicals Directory, Proquest, UK (In Process) Research Bible, Fuchu, Tokyo. JAPAN UDLedge Science Citation Index International Society for Research activity (ISRA) Scientific Indexing Services (SIS) InfoBase Index (In Process) SJIF Impact Factor Scholar Article Impact Factor, SAIF Universal Impact Factor CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Global Impact Factor (GIF) (0.377) IP Indexing (IP Value 3.77) Web of Science Group (Under Process) Directory of Research Journals Indexing Scope Database Academia Academia Doi-Digital Online Identifier Doi-Digital Online Identifier ISSN National Centre Zenodo Indexing International CODEN Service, USA

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT